21 Cecos Provence Alpes Côte d’Azur Nice, Centre de reproduction CHU de Nice, Nice, France
22 Cecos Provence Alpes Côte d’Azur Marseille, CHU La conception, Marseille, France
23 Normandie Univ, UniRouen, EA 4308 “Gametogenesis and Gamete Quality”, Rouen University Hospital, Biology of Reproduction-Cecos Laboratory, Rouen, France
In France, fertility preservation (FP) was until recently very rarely offered to transgender persons despite the existing desire for a child. The proposed treatments, hormone therapy and reassignment surgery, are far from being without risk on gametic quality and production. French law authorizes
fertility preservation before any treatment with sterilizing risks. Thus, several Cecos centers have responded to these new requests. A national multicenter survey was conducted between January 2019 and October 2020 in 28 centers of the French Cecos network. Each center was surveyed to find out how many
TG individuals were coming, being informed, and being managed for FP. During this period, nearly 600 trans individuals presented to a Cecos center. Trans men were significantly younger than trans women. Nearly half of the trans people who came were able to perform oocyte or sperm conservation. However, 66% of trans women did so while only 11% of trans men did. Thus, the vast majority of Cecos centers are able to treat trans people for FP. This is the first study with such a large population.